How to Promote Quality Use of Cost-Effective Medicines

Evaluating Pharmaceuticals for Health Policy and Reimbursement

Volumn , Issue , 2007, Pages 174-189

  Hogerzeil, Hans ^a   Holloway, Kathleen ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Clinical guidelines; Cost effective medicine; Medical costs; Pharmaceutical industry; Quality use

Indexed keywords

EID: 35348959489     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994719.ch11     Document Type: Chapter

References (27)

1. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
2. Laing R, Hogerzeil H, Ross-Degnan D. Ten recommendations to promote improved use of medicines in developing countries. Health Policy Plan 2001;16:13-20.
3. WHO. Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, nr 5. Geneva: WHO, 2002. http://www.who.int/medicines/library/edm_general/6pagers/ppm05en.pdf (accessed 5 February 2004).
4. http://www.health.gov.au/nmp/objectives/index.htm (accessed 2 April 2004).
5. National Prescribing Service Limited homepage. http://www.nps.org.au (accessed 5 February 2004).
6. National Prescribing Service. National Prescribing Curriculum. http://nps.unisa.edu.au (accessed 2 April 2004)
7. Grimshaw J. Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;ii:1317-22.
8. Kafuko J, Zirabamuzaale C, Bagenda D. Impact of national standard treatment guidelines on rational drug use in Uganda health facilities. Kampala: UNICEF/Uganda, 1994.
9. Scottish Intercollegiate Guidelines Network homepage. http://sign.ac.uk (accessed 5 February 2004).
10. Petrie JC. Clinical guidelines in Scotland: a SIGN of the times. Essential Drugs Monitor 1996;22:13-14.
11. Therapeutic Guidelines Ltd. Therapeutic guidelines: antibiotics. North Melbourne, Therapeutic Guidelines Ltd, annual. (see also www.tg.com.au) (accessed 2 April 2004).
12. Weekes LM, Brooks C. Drug and therapeutic committees in Australia: expected and actual performance. Br J Clin Pharmacol 1996;42:551-7.
13. Pedersen CA, Schneider PJ, Santell JP. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing. Am J Health Syst Pharm 2001;58:2251-6.
14. Avorn J, Soumerai SB. Improving drug therapy decision through educational outreach. N Engl J Med 1983;308:1457-63.
15. Soumerai S, Avorn J. Economic and policy analysis of university-based drug "detailing". Med Care 1986;24:313-31.
16. McGavock H. Improving the rationality and economy of family doctor drug prescribing by means of feed-back interviews: the 13-year N-Ireland experience. Geneva, Switzerland: WHO, 1989. DAP/89.
17. Freemantle N, Nazareth I, Eccles M, Wood J, Haines A, and the Evidence-based OutReach (EBOR) trialists. A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract 2002;52:290-5.
18. Walley T, Mrazek M, Mossialos E. Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK. Int J Health Plan Man 2004; in press.
19. De Vries TPGM, Henning RH, Hogerzeil HV, et al. Impact of a short course in pharmacotherapy for undergraduate medical students. Lancet 1995;346:1454-7.
20. De Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing: a practical manual. Geneva, Switzerland: WHO, 1994. WHO/DAP/94.11. http://www.who.int/medicines/library/par/ggprescribing/who-dap-94-11en.pdf (accessed 13 February 2004).
21. Hogerzeil HV (editor). Teachers guide to good prescribing. Geneva, Switzerland: WHO, 2001. WHO/EDM/PAR/2001.2. http://www.who.int/medicines/library/par/teachers_guide.pdf (accessed 13 February 2004).
22. Department of Essential Drugs & Medicines Policy. Major outcomes from the reviews. http://www.drugpromo.info/read-reviews.asp?id=8 (accessed 5 February 2004).
23. WHO. How to develop and implement a national drug policy. Geneva, Switzerland: WHO, 2001:34-5.
24. Trap B, Hansen EH, Hogerzeil HV. Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan 2002;17:288-95.
25. Holloway KA, Gautam BR, Reeves BC. The effects of different kinds of user fees on prescriber costs in rural Nepal. Health Policy Plan 2001;16:421-7.
26. Holloway KA, Gautam BR, Reeves BC. The effects of different kinds of user fees on prescribing quality in rural Nepal. J Clin Epidemiol 2001;54: 1065-71.
27. WHO. Ethical criteria for medicinal drug promotion. Geneva, Switzerland: WHO, 1988.